Tang, Weiting
Beckley, Jacob T. http://orcid.org/0000-0003-2950-6462
Zhang, Jin
Song, Rui
Xu, Yuchen
Kim, Sukhan
Quirk, Michael C.
Robichaud, Albert J.
Diaz, Eva Sarai
Myers, Scott J.
Doherty, James J.
Ackley, Michael A.
Traynelis, Stephen F. http://orcid.org/0000-0002-3750-9615
Yuan, Hongjie http://orcid.org/0000-0002-8127-7145
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD082373)
National Institute of Neurological Disorders and Stroke (NS111619)
Sage Therapeutics
Article History
Received: 19 August 2022
Revised: 18 November 2022
Accepted: 11 December 2022
First Online: 16 January 2023
Declarations
:
: S.F.T. is a member of the SAB for Eumentis Therapeutics and Sage Therapeutics, is a member of the Medical Advisory Board for the GRIN2B Foundation and the CureGRIN Foundation, is an advisor to GRIN Therapeutics and Combined Brain, is co-founder of NeurOp Inc. and AgriThera Inc., and is a member of the Board of Directors of NeurOp Inc. H.Y. is PI on a research grant from Sage Therapeutics to Emory University School of Medicine. S.J.M. is PI on a research grant from GRIN Therapeutics to Emory University School of Medicine. S.F.T., S.J.M., and H.Y. are co-inventors on Emory University-owned Intellectual Property that includes allosteric modulators of NMDA receptor function. M.A.A., J.T.B., J.J.D., M.C.Q., and A.J.R. are employees of Sage Therapeutics.